-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OMS-527 in Substance (Drug) Abuse
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. OMS-527 in Substance (Drug) Abuse Drug Details: OMS-527 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OMS-906 in Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OMS-906 in Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.OMS-906 in Arthritis Drug Details:OMS-906 is under development for the treatment of paroxysmal nocturnal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST-617 in Chemotherapy Induced Oral Mucositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST-617 in Chemotherapy Induced Oral Mucositis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST-617 in Chemotherapy Induced Oral Mucositis Drug Details: ST-617 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OMS-405 in Smoking Cessation
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. OMS-405 in Smoking Cessation Drug Details: OMS-405 (OMS-403) is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OMS-527 in Alcohol Addiction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OMS-527 in Alcohol Addiction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OMS-527 in Alcohol Addiction Drug Details: OMS-527 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OM-002 in Inflammatory Bowel Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OM-002 in Inflammatory Bowel Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OM-002 in Inflammatory Bowel Disease Drug Details: OM-002 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BBT-369 in Primary Mediastinal B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BBT-369 in Primary Mediastinal B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BBT-369 in Primary Mediastinal B-Cell Lymphoma Drug Details: BBT-369 is...
-
Product Insights
NewPancreatic Diseases – Drugs In Development, 2024
Empower your strategies with our Pancreatic Diseases – Drugs In Development, 2024 report and make more profitable business decisions. Pancreatic diseases encompass a range of conditions that affect the pancreas, a vital organ located behind the stomach. The pancreas plays a crucial role in digestion and hormone regulation by producing enzymes for digestion and hormones like insulin and glucagon that regulate blood sugar levels. The Pancreatic Diseases drugs in development market research report provide comprehensive information on the therapeutics under development...
-
Product Insights
NewPancreatitis – Drugs In Development, 2024
Empower your strategies with our Pancreatitis – Drugs In Development, 2024 report and make more profitable business decisions. Pancreatitis is an inflammation of the pancreas. Symptoms include nausea, vomiting, tenderness when touching the abdomen, weight loss, and upper abdominal pain. Predisposing factors include alcoholism, smoking, family history of pancreatitis, infection, injury to the abdomen, and pancreatic cancer. Treatment includes antibiotics and medication to relieve pain. The Pancreatitis drugs in development market research report provide comprehensive information on the therapeutics under development...